NCT00357006View on ClinicalTrials.gov

A Definitive Estrogen Patch Study (ADEPT)

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2011

Study Completion Date

December 31, 2013

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder(Not in Manic Phase)
Interventions
DRUG

Estradiol

100 mcg adjunctive transdermal estradiol

DRUG

Estradiol

200 mcg adjunctive transdermal estradiol

OTHER

placebo

adjunctive transdermal placebo

Trial Locations (1)

3181

Bayside Health - The Alfred Hospital, Melbourne

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

The Alfred

OTHER

NCT00357006 - A Definitive Estrogen Patch Study (ADEPT) | Biotech Hunter | Biotech Hunter